Endocarditis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Rim Halaby (talk | contribs)
No edit summary
Maliha Shakil (talk | contribs)
No edit summary
Line 19: Line 19:
There has been a decline in [[streptococcus viridans]] endocarditis and an increase in staphylococcal endocarditis.
There has been a decline in [[streptococcus viridans]] endocarditis and an increase in staphylococcal endocarditis.


==Risk Factors for Endocarditis==
Adults and children with underlying cardiac conditions placing them at highest risk for adverse outcomes of infective endocarditis (IE) including those with:
* Prosthetic cardiac valve or prosthetic cardiac valve repair
* Previous infective endocarditis
* Congenital heart disease (CHD) associated with
** Unrepaired cyanotic CHD, including palliative shunts and conduits
** Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure
** Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device (which inhibit endothelialization)
* Cardiac transplantation patients who develop cardiac valvulopathy
====What is the Incidence among Patients who do not use Illicit Drugs and have a [[Fever]] in the Emergency Room?====
There is less than a 5% chance of occult endocarditis. Mellors in 1987 found no cases of endocarditis nor of [[staphylococcal]] bacteremia among 135 febrile patients in the emergency room. The upper [http://medinformatics.uthscsa.edu/calculator/calc.shtml confidence interval] for an incidence of 0% among 135 patients is 5%, statistically there is up to a 5% chance of endocarditis among these patients. In contrast, Leibovici found that among 113 non-selected adults admitted to the hospital because of fever there were two cases (1.8% with 95%CI: 0% to 7%) of [[endocarditis]].
====What is the Incidence among Patients who do use Illicit Drugs and have a Fever in the Emergency Room?====
There is about a 10% to 15% prevalence of [[endocarditis]]. This estimate is not substantially changed by whether the doctor believes the patient has a trivial explanation for their fever. Weisse found that 13% of 121 patients had endocarditis. Marantz  also found a prevalence of endocarditis of 13% among such patients in the emergency room with fever. Samet  found a 6% incidence among 283 such patients, but after excluding patients with initially apparent major illness to explain the fever (including 11 cases of manifest endocarditis), there was a 7% prevalence of endocarditis.
====What is the Incidence among Patients with Staphylococcal Bacteremia (SAB)====
One study found a 29% prevalence of [[endocarditis]] in community-acquired SAB versus 5% in nosocomial SAB<ref name=Kaech>{{cite journal | author = Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U | title = Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. | journal = Clin Microbiol Infect | volume = 12 | issue = 4 | pages = 345-52 | year = 2006 | id = PMID 16524411 | doi=10.1111/j.1469-0691.2005.01359.x}}</ref>. However, only 2% of strains were resistant to [[methicillin]] and so these numbers may be low in areas of higher resistance.


==References==
==References==

Revision as of 18:08, 22 September 2015

Endocarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Infective Endocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Diagnosis and Follow-up

Medical Therapy

Intervention

Case Studies

Case #1

Endocarditis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endocarditis epidemiology and demographics

CDC onEndocarditis epidemiology and demographics

Endocarditis epidemiology and demographics in the news

Blogs on Endocarditis epidemiology and demographics

to Hospitals Treating Endocarditis epidemiology and demographics

Risk calculators and risk factors for Endocarditis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The incidence of infective endocarditis is approximately 2-4 cases per 100,000 persons per year worldwide. The prevalence of infective endocarditis among IV drug users ranges from 10 to 15%.

Epidemiology and Demographics

Incidence

The incidence of infective endocarditis is approximately 2-4 cases per 100,000 persons per year worldwide. This rate has not changed in the past 5-6 decades.

Age

Infective endocarditis may occur in a person of any age. The frequency is increasing in elderly individuals, with 25-50% of cases occurring in those older than 60 years of age.

Gender

Infective endocarditis is 3 times more common in males than in females.

Changes in Bacterial Species Causing Endocarditis

There has been a decline in streptococcus viridans endocarditis and an increase in staphylococcal endocarditis.


References

Template:WH Template:WS